Al-Modawat Specialized Medical Co.’s net profit rose 227% to SAR 10.3 million in the first half of 2025, compared to SAR 3.2 million in the prior-year period.
Item | H1 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 37.29 | 55.22 | 48.1 % |
Gross Income | 17.33 | 25.70 | 48.3 % |
Operating Income | 3.79 | 11.22 | 196.3 % |
Net Income | 3.16 | 10.35 | 227.4 % |
Average Shares | 23.75 | 23.75 | - |
Earnings Per Share before unusual items (Riyal) | 0.13 | 0.44 | 227.4 % |
EPS (Riyal) | 0.13 | 0.44 | 227.4 % |
Item | H2 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 38.20 | 55.22 | 44.6 % |
Gross Income | 13.68 | 25.70 | 87.9 % |
Operating Income | 3.78 | 11.22 | 197.1 % |
Net Income | 2.91 | 10.35 | 255.4 % |
Average Shares | 23.75 | 23.75 | - |
Earnings Per Share before unusual items (Riyal) | 0.12 | 0.44 | 255.4 % |
EPS (Riyal) | 0.12 | 0.44 | 255.4 % |
The healthcare services provider noted an increase in the number of patients after the commissioning of the first expansion and improvement in services.
Sequentially, net profit grew 255.4% from SAR 2.91 million in H2 2024.
Shareholders’ equity, no minority interest, rose to SAR 86.98 million as of June 30, 2025, from SAR 78.51 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: